Research programme: RNA therapeutics - Mermaid Bio
Alternative Names: Research programme: intracellular antibodies - Mermaid Bio; Research programme: RNA encoding intracellular nanobodies - Mermaid BioLatest Information Update: 04 Jan 2023
At a glance
- Originator Mermaid Bio; Walter and Eliza Hall Institute of Medical Research
- Developer Mermaid Bio
- Class Antineoplastics; Hepatoprotectants; Immunotherapies; RNA
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Liver cancer; Liver disorders
Most Recent Events
- 04 Jan 2023 Early research in Liver cancer in Germany (Parenteral) as of January 2023 (Mermaid Bio pipeline, January 2023)
- 04 Jan 2023 Early research in Liver disorders in Germany (Parenteral) as of January 2023 (Mermaid Bio pipeline, January 2023)